[{"status": "Terminated", "city": "Horsham", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "67564", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "425 Privet Rd", "address_2": "N/A", "postal_code": "19044-1220", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-1190-2014", "product_description": "QVAR\u00bf (beclomethasone dipropionate HFA), C4 INHALATION AEROSOL in Aluminum Cylinders, Mktd by: Teva Respiratory, LLC, Horsham, PA 19044  Mfd by: 3M Drug Delivery Systems, Northridge, CA 91324.", "product_quantity": "257,832 cylinders", "reason_for_recall": "Failed Impurity/Degradation Specification; for 17-BMP at the 9 and 18 month stability time point", "recall_initiation_date": "20140211", "center_classification_date": "20140403", "termination_date": "20141114", "report_date": "20140409", "code_info": "lot 120088, exp.3/2014, NDC 59310-202-40, 40 mcg,8.7g / 120 metered inhalations, lot 120491, exp. 10/2014, NDC 59310-175-41,40 mcg,7.3g / 100 metered inhalations"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0161-2022", "product_description": "TEST CYPIONATE 200MG/ANASTROZOLE 1MG/DUTASTERIDE 1MG/ML IN OIL  INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "19 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot:  T1005172021:27 BUD: 11/13/2021; T1007222021:42 BUD: 01/18/2022; T1009162021:45 BUD: 03/15/2022", "more_code_info": ""}, {"status": "Ongoing", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090778"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["57237-017", "57237-018", "57237-019"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934"], "spl_id": ["4166006e-ead3-4e01-8b11-07d26ac957ed"], "spl_set_id": ["ea2dc1a6-22d5-4295-9d39-9bf015dc5a89"], "package_ndc": ["57237-017-60", "57237-017-99", "57237-018-30", "57237-018-90", "57237-018-99", "57237-019-30", "57237-019-90", "57237-019-99"], "is_original_packager": [true], "upc": ["0357237018309", "0357237017609", "0357237019306"], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "95756", "recalling_firm": "Rising Pharma Holding, Inc.", "address_1": "2 Tower Center Blvd Ste 1401", "address_2": "", "postal_code": "08816-1149", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0105-2025", "product_description": "Duloxetine Delayed-Release Capsules USP, 20 mg, 60 count bottles, Rx only, Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ  NDC 57237-017-60", "product_quantity": "209,376 bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit", "recall_initiation_date": "20241119", "center_classification_date": "20241205", "report_date": "20241211", "code_info": "a) Lot # DT2022023A, DT2022024A, DT2022025A, DT2022026A, DT2022027A, exp. date Nov-24 DT2023001B, DT2023004A, DT2023005A, DT2023006A, exp. date Jan-25", "more_code_info": ""}, {"status": "Terminated", "city": "Englewood", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91762", "recalling_firm": "Denver Solutions, LLC DBA Leiters Health", "address_1": "13796 Compark Blvd", "address_2": "", "postal_code": "80112-7145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States including VA or other Government facilities", "recall_number": "D-0445-2023", "product_description": "Phenylephrine HCl 20 mg (80 mcg/mL) added to 0.9% Sodium Chloride 250 mL IV Bag, Rx only, Leiters Compounding Health 13796 Compark Blvd Englewood CO 80112, NDC 71449-148-94", "product_quantity": "8,136 units", "reason_for_recall": "CGMP DEVIATIONS", "recall_initiation_date": "20230221", "center_classification_date": "20230307", "termination_date": "20240111", "report_date": "20230315", "code_info": "Lot #: 2231026, Exp. Date 2/23/2023; 2231051, Exp. Date  3/11/2023; 2231156, Exp. Date  5/29/2023; 2231163, Exp. Date  3/26/2023; 223130, Exp. Date 4 5/7/2023; 2231308, Exp. Date 5/11/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Southern Pines", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70656", "recalling_firm": "Health Innovations Pharmacy, Inc", "address_1": "295 Pinehurst Ave Bldg 2", "address_2": "N/A", "postal_code": "28387-7051", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "NC", "recall_number": "D-1005-2015", "product_description": "Dexamethasone 4 mg/mL Iontophoresis, Health Innov Pharmacy, 295 Pinehurst Ave, Southern Pines, NC 28387, (910) 246-5155", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.", "recall_initiation_date": "20150212", "center_classification_date": "20150508", "termination_date": "20170720", "report_date": "20150520", "code_info": "All lots", "more_code_info": ""}, {"status": "Terminated", "city": "Wilsonville", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69519", "recalling_firm": "Oregon Compounding Centers, Inc. dba Creative Compounds", "address_1": "8560 Sw Salish Ln Ste 100", "address_2": "N/A", "postal_code": "97070-9625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Oregon, Washington", "recall_number": "D-0179-2015", "product_description": "CALCIUM CHLORIDE (COMPOUND), 100 mg/mL, Injectable, 10 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070", "product_quantity": "580 mL", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141006", "center_classification_date": "20141031", "termination_date": "20150630", "report_date": "20141112", "code_info": "Lot #: 20140815@47, discard date: 1/28/2015"}, {"status": "Terminated", "city": "Highland", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89334", "recalling_firm": "ULTRAtab Laboratories, Inc.", "address_1": "50 Toc Dr", "address_2": "N/A", "postal_code": "12528-1506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Bulk product was distributed to 3 distributors who may have distributed finished product.", "recall_number": "D-0537-2022", "product_description": "APAP 500 mg SRC Coated (Acetaminophen 500 mg) Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY  NDC 62959-211-00", "product_quantity": "18,772,640 tablets", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20220126", "center_classification_date": "20220209", "termination_date": "20250107", "report_date": "20220216", "code_info": "Product Codes: L211L  Bulk Lots: 18M043, 18M044, 18M045, 19B032, 19B033, 19B034, 19F008, 19F009, 19F010"}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "74746", "recalling_firm": "Clinique International", "address_1": "767 5th Ave", "address_2": "N/A", "postal_code": "10153-0023", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1475-2016", "product_description": "CLINIQUE moisture surge tinted moisturizer broad spectrum SPF 15, 1 FL. OZ.LIQ./30 ml bottle within a carton, Clinique Labs., Dist. New York, N.Y., 10022; New York, London W1K 3BQ; Paris, UPC No. 20714-47478-2, Shade 03 (MF-N)", "product_quantity": "1,771,244 bottles for all shades", "reason_for_recall": "Subpotent Drug: Two of the active sunscreen ingredients, octinoxate and octisalate, are below the specifications for assay.", "recall_initiation_date": "20160517", "center_classification_date": "20160826", "termination_date": "20180614", "report_date": "20160907", "code_info": "all lots"}, {"status": "Ongoing", "city": "Dawsonville", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92054", "recalling_firm": "Direct Rx", "address_1": "94 Worldwide Dr", "address_2": "", "postal_code": "30534-6828", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0507-2023", "product_description": "Alprazolam C-IV, 0.5 mg, 30 Tabs per bottle, Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534, NDC 72189-0240-30.", "product_quantity": "20 bottles", "reason_for_recall": "CGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer.", "recall_initiation_date": "20230322", "center_classification_date": "20230406", "report_date": "20230412", "code_info": "Lot: 11AP2219 Exp. 4/30/23", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA021947"], "brand_name": ["FENTANYL BUCCAL"], "generic_name": ["FENTANYL CITRATE"], "manufacturer_name": ["Mayne Pharma"], "product_ndc": ["51862-636", "51862-634", "51862-635", "51862-637", "51862-638"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["BUCCAL", "SUBLINGUAL"], "substance_name": ["FENTANYL CITRATE"], "rxcui": ["668363", "668364", "668365", "668366", "668367"], "spl_id": ["0ad275cd-db4f-434c-9675-2c7f9655366c"], "spl_set_id": ["918d0e2a-3af3-46e8-ad06-528263e03ba0"], "package_ndc": ["51862-634-01", "51862-634-28", "51862-635-01", "51862-635-28", "51862-636-01", "51862-636-28", "51862-637-01", "51862-637-28", "51862-638-01", "51862-638-28"], "is_original_packager": [true], "unii": ["MUN5LYG46H"]}, "product_type": "Drugs", "event_id": "92133", "recalling_firm": "Teva Pharmaceuticals USA Inc", "address_1": "400 Interpace Pkwy Bldg A", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide", "recall_number": "D-0766-2023", "product_description": "Fentanyl Buccal Tablets CII, 100mcg, packaged in cartons of 28 Buccal Tablets (4 tablets x 7 cards), Rx only, Distributed by: Mayne Pharma, Greenville, NC 27834, NDC 51862-634-28", "product_quantity": "438", "reason_for_recall": "Labeling: Incorrect or Missing Package Insert", "recall_initiation_date": "20230427", "center_classification_date": "20230524", "termination_date": "20240229", "report_date": "20230531", "code_info": "Lot# 42617828, Exp 06/2023; 100020465, Exp 01/2024"}, {"status": "Completed", "city": "Ridgeland", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90798", "recalling_firm": "Carolina Infusion", "address_1": "95 Bees Creek Rd", "address_2": "", "postal_code": "29936-7540", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-1530-2022", "product_description": "TRI-MIX 30/2/20 Injectable, 10 ML vial, Rx only, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936.", "product_quantity": "11 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220826", "center_classification_date": "20220915", "report_date": "20220921", "code_info": "Lots: 07052022@10, BUD: 09/03/2022; 07052022@16, BUD: 09/03/2022; 07122022@11, BUD: 09/08/2022; 07182022@17, BUD: 09/16/2022; 07202022@6, BUD: 09/18/2022; 07252022@9, BUD: 09/23/2022; 0729202222@2, BUD: 09/27/2022; 07292022@13, BUD: 09/27/2022; 08122022@9, BUD: 10/11/2022; 08162022@2, BUD: 10/15/2022; 082620222@1, BUD: 10/25/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Zurich", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA070967"], "brand_name": ["SENSORCAINE"], "generic_name": ["BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "product_ndc": ["63323-461", "63323-472", "63323-463", "63323-468"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INFILTRATION", "PERINEURAL"], "substance_name": ["BUPIVACAINE HYDROCHLORIDE", "EPINEPHRINE BITARTRATE"], "rxcui": ["1012377", "1012384", "1012413", "1012417", "1724786", "1724787", "1724809", "1724810", "1867594", "1867596", "1867618", "1867620"], "spl_id": ["cc1f6507-eb3e-4398-a1d3-0c56a2099e6b"], "spl_set_id": ["bc61a9a6-0a4e-48a9-b908-e5e66b9f23eb"], "package_ndc": ["63323-472-03", "63323-472-17", "63323-472-01", "63323-472-37", "63323-463-01", "63323-463-57", "63323-461-01", "63323-461-57", "63323-468-02", "63323-468-37", "63323-468-01", "63323-468-17"], "is_original_packager": [true], "upc": ["0363323472030", "0363323461010", "0363323463014", "0363323468026", "0363323472016", "0363323468019"], "unii": ["7TQO7W3VT8", "30Q7KI53AK"]}, "product_type": "Drugs", "event_id": "73935", "recalling_firm": "Fresenius Kabi USA, LLC", "address_1": "3 Corporate Dr", "address_2": "", "postal_code": "60047-8930", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1037-2016", "product_description": "Sensorcaine- MPF (Bupivacaine HCI Injection, USP), 0.75% in a 30 mL Single Dose Vial, Rx only, Fresenius Kabi USA LLC, Lake Zurich, IL 60047, NDC 63323-472-37", "product_quantity": "69225 units", "reason_for_recall": "Presence of Particulate Matter: Glass particulate found in sterile injectable product", "recall_initiation_date": "20160425", "center_classification_date": "20160616", "termination_date": "20161020", "report_date": "20160622", "code_info": "Lot #: 6111504, Exp 09/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-131-2014", "product_description": "HCG 300 iu prefilled syringes, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "5349 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"country": "United States", "city": "Cary", "address_1": "3909 3 Oaks Rd", "reason_for_recall": "Cross Contamination With Other Products: Oral care solutions were manufactured by a third party supplier on equipment shared with non-pharmaceutical products", "address_2": "", "product_quantity": "6130 Cases", "code_info": "Product Code: 6904; Lots: 52850, 53281, EXP 08/31/2017; 53300, 53579, EXP 09/30/2017; 54320, EXP 10/31/2017; 54960, EXP 11/30/2017; 55753, EXP 12/31/2017; 56914, EXP 02/28/2018; 57352, EXP 04/30/2018; 57836, EXP 03/31/2018; 58349, EXP 04/30/2018; 59578, EXP 07/31/2018; 60712, EXP 09/30/2018; 61274, EXP 12/31/2018.", "center_classification_date": "20180209", "distribution_pattern": "Distributed Nationwide in the USA and Puerto Rico,  Canada, United Kingdom, Ireland, Netherlands, New Zealand", "state": "IL", "product_description": "Q.Care Oral Cleansing & Suctioning System with 0.12% Chlorhexidine Gluconate (CHG) Oral Rinse q4. Contains 1 Suction Handle, Covered Yankauer and Y-Connector, 2 Untreated Suction Toothbrush packages, 2 Single dose bottles of 0.12% CHG Oral Rinse,  4 Suction Oral Swab packages with Perox-A-Mint solution, 2 Oropharyngeal Suction Catheter packages. Sage Products, Inc., 3909 Three Oaks Road, Cary, IL 60013. Product Code 6904 UPC 6 18029 83008 1", "report_date": "20180221", "classification": "Class II", "openfda": {}, "recalling_firm": "Sage Products Inc", "recall_number": "D-0398-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77992", "termination_date": "20181213", "more_code_info": "", "recall_initiation_date": "20170822", "postal_code": "60013-1804", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Brooklyn", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83136", "recalling_firm": "Infusion Options, Inc.", "address_1": "5924 13th Ave", "address_2": "N/A", "postal_code": "11219-4934", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY only", "recall_number": "D-1797-2019", "product_description": "OXALIPLATIN 145 MG /250 ML D5W IVPB; OXALIPLATIN 154 MG / 250 ML D5W IVPB; OXALIPLATIN 130 MG / 250 ML D5W IVPB; OXALIPLATIN 140 MG / 250 ml D5W IVPB; OXALIPLATIN 162 MG / 250 ML D5W IVPB; OXALIPLATIN 169 MG / 250 ML D5W IVPB; OXALIPLATIN 90 MG / 500 ML D5W IVPB; OXALIPLATIN 50 MG / 250 ML D5W IVPB; OXALIPLATIN 70 MG / 500 ML D5W IVPB; OXALIPLATIN 40 MG / 250 ML D5W IVPB; OXALIPLATIN 155 MG / 250 ML D5W IVPB; OXALIPLATIN 85 MG / 250 ML D5W IVPB  OXALIPLATIN 146 MG / 250 ML D5W IVPB; OXALIPLATIN 246 MG / 500 ML D5W IVPB; OXALIPLATIN 143 MG / 250 ML D5W IVPB; OXALIPLATIN 65 MG / 500 ML D5W IVPB; OXALIPLATIN 80 MG / 500 ML D5W IVPB;   OXALIPLATIN 100 MG / 250 ML D5W IVPB; OXALIPLATIN 150 MG / 250 ML D5W IVPB; OXALIPLATIN 125 MG / 250 ML D5W IVPB; OXALIPLATIN 170 MG / 250 ML D5W IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190612", "center_classification_date": "20190815", "termination_date": "20250321", "report_date": "20190821", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Punxsutawney", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "73167", "recalling_firm": "Bee Xtreme", "address_1": "506 N Penn St", "address_2": "N/A", "postal_code": "15767-1527", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Unknown", "recall_number": "D-0019-2017", "product_description": "La' Trim Plus Dietary Supplement Capsules, 350 mg, 60 count bottles,  Manufactured for Timeless Solutions, 1810 E Sahara Ave #100, Las Vegas, Nevada 89104,   distributed by BeeXtreme LLC, Punxsutawney PA", "product_quantity": "589 bottles", "reason_for_recall": "Marketed without an Approved NDA/ANDA; FDA analysis found them to contain sibutramine and phenolphthalein", "recall_initiation_date": "20151223", "center_classification_date": "20161012", "termination_date": "20170130", "report_date": "20161019", "code_info": "All Lots"}, {"status": "Terminated", "city": "Johnson City", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA207733"], "brand_name": ["NYSTATIN CREAM"], "generic_name": ["NYSTATIN CREAM"], "manufacturer_name": ["Crown Laboratories"], "product_ndc": ["0316-0221"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["NYSTATIN"], "rxcui": ["543546"], "spl_id": ["42ee71fd-bcfd-a17d-e063-6294a90ab4bb"], "spl_set_id": ["5a2b6fee-1437-0c3a-e053-2991aa0a3443"], "package_ndc": ["0316-0221-15", "0316-0221-30"], "is_original_packager": [true], "upc": ["0303160221156"], "nui": ["N0000175498", "M0017172"], "pharm_class_epc": ["Polyene Antifungal [EPC]"], "pharm_class_cs": ["Polyenes [CS]"], "unii": ["BDF1O1C72E"]}, "product_type": "Drugs", "event_id": "85833", "recalling_firm": "Crown Laboratories", "address_1": "349 Lafe Cox Dr", "address_2": "N/A", "postal_code": "37604-7469", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA.", "recall_number": "D-1339-2020", "product_description": "Nystatin Cream, USP 100,000 units per gram, 15 grams, Rx Only, Manufactured and Distributed by: Crown Laboratories, Inc. Johnson City, TN 37604, NDC 0316-0221-15", "product_quantity": "35,931 tubes", "reason_for_recall": "Subpotent Drug: Out of specification for assay at the 9-month interval for Nystatin Cream, USP.", "recall_initiation_date": "20200610", "center_classification_date": "20200624", "termination_date": "20211105", "report_date": "20200701", "code_info": "Lot: Y0378, EXP 07/2021"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93103", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0030-2024", "product_description": "HYDROmorphone in dextrose 5%, 3 mg/30 mL, (0.1 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2013-2", "product_quantity": "274 30 mL syringes", "reason_for_recall": "Lack of assurance of sterility:", "recall_initiation_date": "20230921", "center_classification_date": "20231004", "termination_date": "20250319", "report_date": "20231011", "code_info": "Lot:17-275266, Exp. 10/2/2023; 17-275666, Exp. 10/8/2023."}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0823-2019", "product_description": "Dr. King's SafeCare Rx Menstrual Cramps & Irregularities, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955000426, NDC 57955-0004-2", "product_quantity": "144 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 083116E Exp. 08/19; 052616D Exp. 05/19"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "77071", "recalling_firm": "Akorn, Inc.", "address_1": "1925 W Field Ct Ste 300", "address_2": "N/A", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0697-2017", "product_description": "IC-Green (indocyanine green for injection, USP), 25 mg, packaged in a kit containing six vials of 25 mg lyophilized powder, Rx only,  Manufactured by:  Akorn, Inc., NDC 17478-701-02", "product_quantity": "1,292 kits", "reason_for_recall": "Product is being recalled due to low pH value.", "recall_initiation_date": "20170420", "center_classification_date": "20170509", "termination_date": "20190221", "report_date": "20170517", "code_info": "Kit Lot #031126; Exp 8/2018"}, {"status": "Terminated", "city": "Bristol", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82554", "recalling_firm": "Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy", "address_1": "Attn: Cleve Anderson", "address_2": "310 Bluff City Hwy", "postal_code": "37620-4602", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1199-2019", "product_description": "Phenol 10% Injection, 5 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.", "product_quantity": "N/A", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190402", "center_classification_date": "20190418", "termination_date": "20210924", "report_date": "20190424", "code_info": "All Lots"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0062-2015", "product_description": "Bacteriostatic water for injection packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "600 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 03082014@2, Exp 9/4/2014; 04142014@8, Exp 10/11/2014; 05242014@2, Exp 11/20/2014; 06202014@20, Exp 12/17/2014; 08192014@33, Exp 2/15/2015", "more_code_info": ""}, {"status": "Terminated", "city": "West Columbia", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M012"], "brand_name": ["ASTHMANEFRIN"], "generic_name": ["RACEPINEPHRINE HYDROCHLORIDE"], "manufacturer_name": ["Nephron Pharmaceuticals Corporation"], "product_ndc": ["0487-2784"], "product_type": ["HUMAN OTC DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["RACEPINEPHRINE HYDROCHLORIDE"], "rxcui": ["212349", "310133"], "spl_id": ["2b3667be-158a-49eb-e063-6394a90aad34"], "spl_set_id": ["80480838-832c-4fdd-9f8e-f6f877ae3549"], "package_ndc": ["0487-2784-01"], "is_original_packager": [true], "upc": ["0304872784014", "304872784014"], "unii": ["336096P2WE"]}, "product_type": "Drugs", "event_id": "91451", "recalling_firm": "Nephron Sc Inc", "address_1": "4500 12th Street Ext", "address_2": "N/A", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States including Puerto Rico. Guatamala", "recall_number": "D-0175-2023", "product_description": "Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator (racephedrine, USP 11.25), 30x0.5 mL Sterile Vials each in a foil pouch,  NDC 0487-2784-01 UPC 3 04872 78401 4", "product_quantity": "387,000 vials", "reason_for_recall": "Short Fill", "recall_initiation_date": "20230113", "center_classification_date": "20230123", "termination_date": "20241011", "report_date": "20230201", "code_info": "Lot #: 126451 Exp. 04/30/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Plano", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72958", "recalling_firm": "TexasStar Pharmacy", "address_1": "3033 W Parker Rd Ste 100", "address_2": "N/A", "postal_code": "75023-8000", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "TX", "recall_number": "D-0733-2016", "product_description": "Baclofen, 2.5 mg/mL INJ, in 100 mL vial, Rx Only, TexasStar Pharmacy, Plano, Texas 75023", "product_quantity": "700 mL (7 vials of 100 mL)", "reason_for_recall": "Lack of  assurance of sterility", "recall_initiation_date": "20151229", "center_classification_date": "20160302", "termination_date": "20161117", "report_date": "20160309", "code_info": "Lot # 07142015#7192@1,  Exp 09/12/2015; 09112015#7192@1, Exp 11/10/2015; 10082015#7192@9, Exp 12/07/2015; 11302015#71920@1, Exp 1/30/2015"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "40 ml total", "code_info": "All lots distributed between November 2014 and May 2015;  04012015@78, 5/31/2015; 04222015@61, 6/21/2015; 04302015@55, 6/29/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "HCG 1,500 IU/ml Injection, Multi-Dose Vial, Sterile, Refrigerate The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1526-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Irving", "address_1": "8300 Esters Blvd Ste 940", "reason_for_recall": "Labeling: Label Error on Declared Strength; Firm states that erroneous potency information was found on the label.", "address_2": "", "product_quantity": "296 units", "code_info": "Lot Numbers 101751/A, Exp: 05/16, CAS: 9002-61-3; 101752/A, Exp: 05/16,  CAS 9002-61-3;  and 101799/A, Exp: 05/16, CAS: 9002-61-3.  NDC 38779-2673-1, NDC 38779-2673-2, and NDC 38779-2673-6.", "center_classification_date": "20140425", "distribution_pattern": "Nationwide", "state": "TX", "product_description": "Human Chorionic Gonadotropin, EP (HCG) in 5 mu. 2 mu, and 1 mu packages, For use and distribution in prescription compounding, manufacturing, processing or repacking only in accordance with FDA regulations and applicable law.  Potency 5489.6IU/mg.  Packed by Medisca, Inc. Irving, TX, 75063, USA      NDC 38779-2673-1, NDC 38779-2673-2, and NDC 38779-2673-6.      Lot Numbers 101751/A, Exp: 05/16, CAS: 9002-61-3; 101752/A, Exp: 05/16,  CAS 9002-61-3;  and 101799/A, Exp: 05/16, CAS: 9002-61-3", "report_date": "20140507", "classification": "Class I", "openfda": {}, "recalling_firm": "Medisca Inc.", "recall_number": "D-1263-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "67114", "termination_date": "20161116", "more_code_info": "", "recall_initiation_date": "20131021", "postal_code": "75063-2272", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Southfield", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65876", "recalling_firm": "Beacon Hill Medical Pharmacy, P.C.", "address_1": "18161 W 13 Mile Rd", "address_2": "Suite A1", "postal_code": "48076-1113", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "USA nationwide", "recall_number": "D-953-2013", "product_description": "EDETATE DISODIUM  150 MG/ML INJECTABLE, all presentations, FOR INTRAVENO AND SQ USE ONLY, STERILE, RX ONLY, Compounded by Beacon Hill Medical Pharmacy PC, dba Rxtra Solutions, Southfield, MI", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance", "recall_initiation_date": "20130726", "center_classification_date": "20130910", "termination_date": "20140718", "report_date": "20130918", "code_info": "07172013@4, 01222013@14, 03072013@10, 04032013@1, 05162013@17, 06042013@30m, 07092013@17, and 07262013@2", "more_code_info": ""}, {"status": "Terminated", "city": "Levittown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82889", "recalling_firm": "Torrent Pharma Inc", "address_1": "2091 Hartel Ave", "address_2": "N/A", "postal_code": "19057-4506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 9 distributors, direct accounts and relabelers who may have further distributed the product throughout the United States.", "recall_number": "D-1354-2019", "product_description": "Nasal Decongestant Spray Regular, Oxymetazoline HCl 0.05%, a) 0.5 FL. oz. (15 mL) bottle, NDC:0904-5711-35, b) 1 FL. oz. (30 mL) bottle, NDC: 0904-5711-30, Distributed by Major Pharmaceuticals, Livonia MI 48152.", "product_quantity": "3,788,502 bottles", "reason_for_recall": "cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).", "recall_initiation_date": "20190521", "center_classification_date": "20190613", "termination_date": "20201006", "report_date": "20190619", "code_info": "Lot #s: a) 17E032, Exp. 05/2019; 17F011; 17F020, Exp. 06/2019; 17G003; 17G011, Exp. 07/2019; 17H016, Exp. 08/2019; 17J005; 17J017; 17J026, Exp. 09/2019; 17K029, Exp. 10/2019; 17L027, Exp. 11/2019; 18A003; 18A004; 18A033, Exp. 01/2020; 18B011, Exp. 02/2020; 18C029, Exp. 03/2020; 18D019; 18D025, Exp. 04/2020; 18F014, Exp. 06/2020; 18H029, Exp. 08/2020; 18J007; 18J018, Exp. 09/2020; 18K007; 18K026, Exp. 10/2020; 19A012, Exp. 01/2021.     b) 17E011, Exp. 05/2019; 17E012, Exp. 06/2019; 17G019; 17G023, Exp. 07/2019; 17H011, Exp. 08/2019; 17J029, Exp. 09/2019; 17K005, Exp. 10/2019; 17M005; 17M018, Exp. 12/2019; 18C001; 18C004, Exp. 03/2020; 18F032; 18F019, Exp. 06/2020."}, {"status": "Terminated", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86006", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "N/A", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to MN.", "recall_number": "D-1387-2020", "product_description": "Carbamazepine 200 mg Tablets, 100-unit dose tablets per box, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-2489-00 for box; 70518-2489-01 per unit dose.", "product_quantity": "498 tablets", "reason_for_recall": "FAILED DISSOLUTION SPECIFICATION: Low out-of-specification (OOS) dissolution results obtained during routine stability testing.", "recall_initiation_date": "20200629", "center_classification_date": "20200714", "termination_date": "20200914", "report_date": "20200722", "code_info": "Lot #: B0796217-020920, Exp. Date: 02/28/2021"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: TEMAZEPAM, Capsule, 7.5 mg may have potentially been mislabeled as one of the following drugs:  CALCIUM CITRATE, Tablet, 200 mg Elemental Calcium, NDC 00904506260, Pedigree: AD28333_1, EXP: 5/8/2014;  VALSARTAN, Tablet, 160 mg, NDC 00078035934, Pedigree: AD49414_7, EXP: 5/17/2014.", "address_2": "", "product_quantity": "200 Capsules", "code_info": "TEMAZEPAM, Capsule, 7.5 mg has the following codes:   Pedigree: AD22861_7, EXP: 5/8/2014;  Pedigree: AD49418_1, EXP: 5/17/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "TEMAZEPAM, Capsule, 7.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378311001.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-905-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0967-2020", "product_description": "Methylcobalamin Injection, METHYLCOBALAMIN 1 MG/ML INJECTABLE, For IV, IM, SC Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0331-3", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 07232019+52730, Exp 1/19/2020; 07232019+52732, Exp 1/19/2020; 07242019+52748, Exp 1/20/2020; 11212019+53272, Exp 5/19/2020"}, {"status": "Terminated", "city": "Tampa", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "74339", "recalling_firm": "Virtus Pharmaceuticals, Llc", "address_1": "2649 Causeway Center Dr", "address_2": "N/A", "postal_code": "33619-6102", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1048-2016", "product_description": "VP-CH-PNV Prenatal/Postnatal capsules, prenatal supplement, 30-count bottle, Rx only, Manufactured for: Virtus Pharmaceuticals, LLC, Tampa, FL 33619, NDC 69543-224-30", "product_quantity": "1,586 bottles", "reason_for_recall": "Defective delivery system: Softgel capsules are leaking.", "recall_initiation_date": "20160516", "center_classification_date": "20160622", "termination_date": "20180821", "report_date": "20160629", "code_info": "Lot # 21601142 Exp 12/17"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: ASPIRIN/ER DIPYRIDAMOLE, Capsule, 25 mg/200 mg may have potentially been mislabeled as the following drug:  THIAMINE HCL, Tablet, 100 mg, NDC 00904054460, Pedigree:  AD70639_1, EXP: 5/29/2014;  LEVOTHYROXINE SODIUM, Tablet, 88 mcg, NDC 00781518392, Pedigree:  W003439, EXP: 6/20/2014;  ZINC SULFATE, Capsule, 220 mg, NDC 60258013101, Pedigree:  W003641, EXP: 6/25/2014.", "address_2": "", "product_quantity": "300 Capsules", "code_info": "ASPIRIN/ER DIPYRIDAMOLE, Capsule, 25 mg/200 mg has the following codes:   Pedigree:  AD70639_4, EXP: 7/28/2013;  Pedigree:  W003468, EXP: 8/19/2013;  Pedigree:  W003644, EXP: 8/24/2013.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ASPIRIN/ER DIPYRIDAMOLE, Capsule, 25 mg/200 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00597000160.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-980-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0744-2020", "product_description": "HYDROMORPHONE 3MG/ML  INJ in 20 mL syringe Assurance Infusion (713) 533-8800", "product_quantity": "2 syringes", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lots: 12162019@14 Exp. 12/25/2019; 12102019@19 Exp. 12/19/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73925", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-0025-2017", "product_description": "atropine Sulfate Injection, 0.4 mg per mL, 1 mg per 2.5 mL, 2.5 mL Total Volume in a syringe, For IV use, Rx only, PharMEDium, Product code 2R3324.", "product_quantity": "4407 syringes", "reason_for_recall": "Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.", "recall_initiation_date": "20150717", "center_classification_date": "20161012", "termination_date": "20170623", "report_date": "20161019", "code_info": "Lot Numbers: 15146085M, 15147088M, 15149011M, 15149109M, 15150093M, 151730001M, 151740139M, 151900018M, 151910014M, Exp between 07/15/15-10/12/15"}, {"status": "Terminated", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72746", "recalling_firm": "Sentara Enterprises", "address_1": "535 Independence Pkwy Ste 300", "address_2": "N/A", "postal_code": "23320-5176", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "U.S. Including: VA, NC", "recall_number": "D-0633-2016", "product_description": "FLUCONAZOLE IN NACL 400MG in NS, Packaged in 200ML Homepumps, Rx Only. SENTARA HOME HEALTH SENTARA RX, 535 Independence Pkwy ste.300, Chesapeake, VA 23320-5176.", "product_quantity": "7 Bags", "reason_for_recall": "Lack of Assurance of Sterility: Product sterility cannot be guaranteed.", "recall_initiation_date": "20150918", "center_classification_date": "20160128", "termination_date": "20160629", "report_date": "20160203", "code_info": "All Lots compounded between 11-Sep-15 and 17-Sep-15. Expiry: 25-Sep-15"}, {"status": "Terminated", "city": "Springfield", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "64182", "recalling_firm": "Reumofan Plus USA", "address_1": "737 Buttonwood Dr.", "address_2": "N/A", "postal_code": "19064", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide through internet sales.", "recall_number": "D-837-2013", "product_description": "Reumofan Plus, 30-count tablets per bottle, distriubted by Reumofan Plus USA, LLC and Reumofan USA, LLC, Springfield, PA, and manufactured by Riger Natural S.A., Mexico.", "product_quantity": "586 bottles", "reason_for_recall": "Marketed without an approved NDA/ANDA: Product may contain undeclared active pharmaceutical ingredients Diclofenac Sodium, Dexamethasone, and Methocarbamol.", "recall_initiation_date": "20130104", "center_classification_date": "20130802", "termination_date": "20150129", "report_date": "20130814", "code_info": "Lot #: 99515, Exp 09/2016"}, {"status": "Ongoing", "city": "Englewood", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96742", "recalling_firm": "Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)", "address_1": "88 Inverness Cir E Unit A204", "address_2": "", "postal_code": "80112-5521", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "USA Nationwide", "recall_number": "D-0487-2025", "product_description": "Nicotinamide adenine dinucleotide (NAD+): 100mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112", "product_quantity": "16 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20250521", "center_classification_date": "20250620", "report_date": "20250702", "code_info": "Lot: GA37484", "more_code_info": ""}, {"status": "Terminated", "city": "Spokane", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83253", "recalling_firm": "First Pharma Associates LLC dba Riverpoint Pharmacy", "address_1": "1802 N Monroe St", "address_2": "", "postal_code": "99205-4528", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "ID, WA only", "recall_number": "D-1476-2019", "product_description": "Hydroxocobalamin 10 mg/mL Injection (ALT) Solution, 30 mL vial, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343-6252", "product_quantity": "60 mL", "reason_for_recall": "Lack of Assurance of Sterility.", "recall_initiation_date": "20190626", "center_classification_date": "20190711", "termination_date": "20230606", "report_date": "20190717", "code_info": "Lot #: 05282019@53, Exp. 08/26/2019 and Exp. 08/28/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Moses Lake", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71806", "recalling_firm": "JD & SN Inc., dba Moses Lake Professional Pharmacy", "address_1": "1555 Pilgrim St", "address_2": "N/A", "postal_code": "98837-4623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0153-2016", "product_description": "VITAMIN B-COMPLEX, Injectable Solution, Syringe size: 30 mL, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA  98837, (509)764-2314", "product_quantity": "3 syringes", "reason_for_recall": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry", "recall_initiation_date": "20150724", "center_classification_date": "20151027", "termination_date": "20160413", "report_date": "20151104", "code_info": "t04172015@20"}, {"status": "Terminated", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65019", "recalling_firm": "Nora Apothecary and Alternative Therapies, Inc.", "address_1": "1101 E 86th St", "address_2": "N/A", "postal_code": "46240-3729", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-483-2013", "product_description": "Methylcobalamin Inj 1mg/ml MDV, 10 ml, 15 ml, 20 ml, 30 ml, 4x30 ml  Subcutaneous, 90 day expiration,", "product_quantity": "14", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.", "recall_initiation_date": "20130422", "center_classification_date": "20130529", "termination_date": "20140801", "report_date": "20130605", "code_info": "All products within their expiration date including those dated 90 days prior to April 19, 2013 (Jan. 2013 to April 19, 2013)."}, {"country": "United States", "city": "Asheville", "address_1": "752 Biltmore Ave", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "address_2": "", "product_quantity": "", "code_info": "All lot numbers within expiry.", "center_classification_date": "20140304", "distribution_pattern": "NC", "state": "NC", "product_description": "Idoxuridine 0.1% Ophthalmic", "report_date": "20140312", "classification": "Class II", "openfda": {}, "recalling_firm": "Natures Pharmacy & Compounding Center", "recall_number": "D-1122-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "66856", "termination_date": "20140424", "more_code_info": "", "recall_initiation_date": "20131101", "postal_code": "28803-2558", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90340", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "nationwide within the United States", "recall_number": "D-1155-2022", "product_description": "Clonazepam Orally Disintegrating Tablets, USP, 0.125mg, Rx Only, 60 Tablets, Mfd. by: Sun Pharmaceutical Industries Ltd. Mumbai, India, Dist. by: Sun Pharmaceutical Industries In., Cranbury, NJ 08512,  NDC 57664-783-68, packaged in bottles.", "product_quantity": "4608 bottles", "reason_for_recall": "Failed Tablet/Capsule Specification; oversized tablet found in a bottle", "recall_initiation_date": "20220603", "center_classification_date": "20220622", "termination_date": "20230818", "report_date": "20220629", "code_info": "Lot #: MHC1430A, Exp. Date 09/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Gardena", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88960", "recalling_firm": "VIRGIN SCENT INC", "address_1": "16325 S Avalon Blvd", "address_2": "", "postal_code": "90248-2909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the U.S.A", "recall_number": "D-0784-2022", "product_description": "artnaturals Hand Sanitizer", "product_quantity": "46,368 Bottles", "reason_for_recall": "CGMP Deviations: Other lots recalled because they were manufactured using common ingredients as the contaminated lot", "recall_initiation_date": "20211026", "center_classification_date": "20220422", "termination_date": "20240731", "report_date": "20220427", "code_info": "Lot: G20154A, G20155A, EXP 6/1/2022;", "more_code_info": ""}, {"country": "United States", "city": "Little Rock", "address_1": "1527 S Bowman Rd Ste D", "reason_for_recall": "Lack of Assurance of Sterility: Sterility of product is not assured.", "address_2": "", "product_quantity": "1 Bag", "code_info": "Compounded on 05/28/15, Discard After: 06/11/15", "center_classification_date": "20150701", "distribution_pattern": "United States including: Arkansas", "state": "AR", "product_description": "Fluorouracil 4600mg / D5W 292 mL, Qty: 1 292 mL Bag, Rx Only.  Compounded by: United Medical IV Center (Little Rock) 1527 South Bowman Rd. Ste. D Little Rock, AR 72211-4200.", "report_date": "20150708", "classification": "Class II", "openfda": {}, "recalling_firm": "Lincare, Inc.", "recall_number": "D-1180-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71415", "termination_date": "20170216", "more_code_info": "", "recall_initiation_date": "20150528", "postal_code": "72211-4200", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Fajardo", "address_1": "Road 195, Km 1.1", "reason_for_recall": "Chemical contamination: Firm's inspection discovered the  presence of 2-phenylphenol in the product due to migration from the cardboard cartons in which the product is packaged.", "address_2": "Union Street", "product_quantity": "17,136 bottles", "code_info": "Lot # 507694A; exp 02/13  Lot # 510041C; exp 05/13", "center_classification_date": "20130430", "distribution_pattern": "US Nationwide and Puerto Rico", "state": "PR", "product_description": "Jevantique (norethindrone acetate and ethinyl estradiol) tablets; 1.0 mg/5.0 mcg, 90 count bottle (NDC# 52544-237-19), Rx only, Manufactured by Warner Chilcott Company, LLC, Fajardo, PR 00738, Distributed by Watson Pharma, Inc. Corona, CA 92880.", "report_date": "20130508", "classification": "Class III", "openfda": {}, "recalling_firm": "Warner Chilcott Company LLC", "recall_number": "D-304-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "64459", "termination_date": "20140609", "more_code_info": "", "recall_initiation_date": "20130215", "postal_code": "00738", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0572-2017", "product_description": "SUPREME CREAM (Retinoic acid 0.05%, hydroquinone 6%, kojic acid 3%, Alpha Arbutin otc 2%, Azeliac acid 2%), Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"country": "United States", "city": "Tigard", "address_1": "8800 SW Commercial St", "reason_for_recall": "Labeling: Label Mix-Up: Customer complaint received that a bottle labeled as Senna Laxative contained only tablets of Naproxen Sodium 220 mg.", "address_2": "", "product_quantity": "2,400 bottles", "code_info": "Lot # 352300, Exp 01/19", "center_classification_date": "20180209", "distribution_pattern": "Nationwide in the USA", "state": "OR", "product_description": "Senna Laxative (sennosides) tablets, 8.6 mg, 100-count bottles, Manufactured for: Basic Drugs, Inc., Vandalia, Ohio 45377, UPC Code 3 07610 22020 1.", "report_date": "20180221", "classification": "Class I", "openfda": {}, "recalling_firm": "Magno Humphries Laboratories, Inc", "recall_number": "D-0342-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "78952", "termination_date": "20191206", "more_code_info": "", "recall_initiation_date": "20180117", "postal_code": "97223-6252", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx #:  0389781", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "HUMULIN-R INSULIN, 10ML VIAL** 100U/ML INJECTABLE\t10 MLS (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1532-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090778"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["57237-017", "57237-018", "57237-019"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934"], "spl_id": ["4166006e-ead3-4e01-8b11-07d26ac957ed"], "spl_set_id": ["ea2dc1a6-22d5-4295-9d39-9bf015dc5a89"], "package_ndc": ["57237-017-60", "57237-017-99", "57237-018-30", "57237-018-90", "57237-018-99", "57237-019-30", "57237-019-90", "57237-019-99"], "is_original_packager": [true], "upc": ["0357237018309", "0357237017609", "0357237019306"], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "96427", "recalling_firm": "Rising Pharma Holding, Inc.", "address_1": "2 Tower Center Blvd Ste 1401", "address_2": "N/A", "postal_code": "08816-1149", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0277-2025", "product_description": "Duloxetine Delayed-Release Capsules, USP, 30 mg, 1,000-count bottle, Rx only, Distributed by: Rising Health, LLC, Saddle Brook, NJ 07663, NDC 57237-018-99", "product_quantity": "1223 bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit.", "recall_initiation_date": "20250305", "center_classification_date": "20250314", "report_date": "20250326", "code_info": "Lot #: DTB23111A, Exp 8/31/2025"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82421", "recalling_firm": "MSM Nutraceuticals, LLC", "address_1": "2103 W Parkside Ln Ste 107", "address_2": "N/A", "postal_code": "85027-1245", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1129-2019", "product_description": "Dr. Berne's MSM DROPS 15% Solution, Net Wt. 30ml/1.014 OZ, Distributed by: Dr. Berne's Whole Heallth Products, 400 Hillsboro Technology Drive, Deerfield BEach, FL 33441 SKU#182 UPC 00854582001036", "product_quantity": "500 30 mL bottles", "reason_for_recall": "Lack of Assurance of Sterility: Product is not terminally sterialized and not tested per USP 71.", "recall_initiation_date": "20190312", "center_classification_date": "20190415", "termination_date": "20230517", "report_date": "20190424", "code_info": "Lot # 1808051, Exp. Date 01/01/22"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-926-2015", "product_description": "Thimerosal active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "1010 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Ongoing", "city": "Nicholasville", "state": "KY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89909", "recalling_firm": "TMC Acquisition LLC dba Tailor Made Compounding", "address_1": "200 Moore Dr", "address_2": "", "postal_code": "40356-8512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-1234-2022", "product_description": "Testosterone Cypionate/Enanthate 100/100mg/ml, a) 2 mL-vial, b) 4 mL-vial c) 10 mL-vial,  Room temperature, Tailor Made Compounding", "product_quantity": "58 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220307", "center_classification_date": "20220714", "report_date": "20220720", "code_info": "Batch#: Expiry: a) 01142227A1, Exp 7/13/2022; b) 12012126A2, Exp 5/30/2022; 02042203A1, Exp 8/3/2022; c) 01052207A1, Exp 7/4/2022.", "more_code_info": ""}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "26 ml total", "code_info": "All lots distributed between November 2014 and May 2015;  03102015@57 9/6/2015  03092015@71 9/5/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Tri-Mix (20/2.5/20)  Injectable, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1770-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "St Petersburg", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65125", "recalling_firm": "THE COMPOUNDING SHOP, INC.", "address_1": "4000 Park St N", "address_2": "N/A", "postal_code": "33709-4034", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Florida, California, Minnesota, and Maine", "recall_number": "D-571-2013", "product_description": "MIC (Methionine, Inositol, and Choline) Injectable, 30 mL vials, compounded by The Compounding Shop, St. Petersburg, FL", "product_quantity": "10 vials of 30 mL each", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "recall_initiation_date": "20130502", "center_classification_date": "20130604", "termination_date": "20240930", "report_date": "20130612", "code_info": "All Lots"}, {"status": "Ongoing", "city": "Amman", "state": "", "country": "Jordan", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92974", "recalling_firm": "AMMAN PHARMACEUTICAL INDUSTRIES", "address_1": "Building 108", "address_2": "Street A3, King Abdullah Ii Industrial City", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to two (2) direct accounts in RI and CO.", "recall_number": "D-1161-2023", "product_description": "TRP Natural Eyes, Pink Eye Relief, Sterile Eye drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502 NDC: 17312-013-15.", "product_quantity": "293,400 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230901", "center_classification_date": "20230915", "report_date": "20230927", "code_info": "Lot: IV001 EXP:06/25; Lot:IV002 EXP: 11/24; Lot:IV004 EXP:01/25", "more_code_info": ""}, {"status": "Terminated", "city": "Williamstown", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "66406", "recalling_firm": "Haute Health, LLC", "address_1": "614 Atlanta Ct", "address_2": "N/A", "postal_code": "08094-3549", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide and internationally via internet sales.", "recall_number": "D-1237-2014", "product_description": "Virilis Pro, 450mg/capsule, Packaged in a 1 and 2 capsule blister packs and 10 capsule bottles, Manufactured for Haute Health Williamstown, NJ 08094 website: http://www.virilispro.com", "product_quantity": "82,944 capsules", "reason_for_recall": "Marketed without an Approved NDA/ANDA: Dietary supplement may contain amounts of  active ingredients found in some FDA-approved drugs for erectile dysfunction (ED) making the dietary supplement an unapproved drug.", "recall_initiation_date": "20130927", "center_classification_date": "20140415", "termination_date": "20150129", "report_date": "20140423", "code_info": "All lot codes and expiration dates."}, {"country": "United States", "city": "Lake Forest", "address_1": "275 N Field Dr", "reason_for_recall": "Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags.", "address_2": "", "product_quantity": "40,988 units", "code_info": "Lot #: 95-057-JT, Exp 11/12", "center_classification_date": "20130621", "distribution_pattern": "Nationwide Puerto Rico, U.S. Virgin Island, Libya, Saudi Arabia", "state": "IL", "product_description": "1.5% Glycine Irrigation, USP, 3000 mL, Rx Only, Hospira, Inc., Lake Forest, IL 60045 NDC 0409-7974-08", "report_date": "20130703", "classification": "Class II", "openfda": {}, "recalling_firm": "Hospira Inc.", "recall_number": "D-618-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "61918", "termination_date": "20150717", "more_code_info": "", "recall_initiation_date": "20120504", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Conway", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72179", "recalling_firm": "US Compounding Inc", "address_1": "1270 Don's Lane", "address_2": "N/A", "postal_code": "72032", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0269-2016", "product_description": "MIC-Combo, 30 mL Multi-Dose Vial, For Deep IM Injection Only, Rx only, Compounded by US Compounding Pharmacy, Conway, Arkansas, 72032, NDC 62295-3127-06.", "product_quantity": "1,736 vials", "reason_for_recall": "Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.", "recall_initiation_date": "20150912", "center_classification_date": "20151117", "termination_date": "20170330", "report_date": "20151125", "code_info": "Lot Code: 20150105@18 BUD: 10/28/2015, 20150805@34 BUD: 11/4/2015, 20152603@12 BUD: 9/21/2015, 20153004@20 BUD: 10/27/2015, 20150805@34 BUD: 11/4/2015, 20152603@12 BUD: 9/21/2015, 20153004@20 BUD: 10/27/2015"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78828", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0444-2018", "product_description": "Dexamethasone Sodium Phosphate in all strengths, all doses, and all packaging.", "product_quantity": "Unknown", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20171227", "center_classification_date": "20180220", "termination_date": "20200507", "report_date": "20180228", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Corona", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "78106", "recalling_firm": "Aidarex Pharmaceuticals LLC", "address_1": "595 N Smith Ave Ste B", "address_2": "N/A", "postal_code": "92880-6920", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Product was distributed in Florida", "recall_number": "D-0053-2018", "product_description": "ENALAPRIL MALEATE Tablets, USP, 5MG, 90-count bottles, Rx only, MFG: Wockhardt Ltd., India; Packaged By: Aidarex Pharmaceuticals; NDC 33261-0693-90.", "product_quantity": "12 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: manufacturer of product recalled this repackaged lot due to out of specification results for related compound.", "recall_initiation_date": "20170905", "center_classification_date": "20171026", "termination_date": "20171201", "report_date": "20171101", "code_info": "Lot #: 55097-2, 56085-1, Exp 11/30/2018"}, {"status": "Terminated", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "78487", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "N/A", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide in the USA", "recall_number": "D-0230-2018", "product_description": "bupPROPion HCL Extended-Release Tablets, USP (XL) 300 mg, 500-count bottle, Rx only, Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A. NDC: 0378-2009-05", "product_quantity": "1,414/500 count bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Mylan Pharmaceuticals Inc. is conducting a voluntary recall due to related out of specification compound results obtained during routine stability testing.", "recall_initiation_date": "20171103", "center_classification_date": "20180119", "termination_date": "20180614", "report_date": "20180131", "code_info": "Lot # 3077281, EXP 06-2018"}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0028-2019", "product_description": "Rhinall (phenylephrine hydrochloride) Nasal Decongestant Nose Drops, 0.25%, 1 FL OZ (30 mL) bottle, Distributed by: Scherer Labs International, LLC., 330 Carswell Ave., Daytona Beach, FL 32117, UPC 3 02747 52531 1.", "product_quantity": "4040 bottles", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Conway", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72179", "recalling_firm": "US Compounding Inc", "address_1": "1270 Don's Lane", "address_2": "N/A", "postal_code": "72032", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0267-2016", "product_description": "Methylprednisolone/Lidocaine (40 mg/mL/1%) 10 mL Multi-Dose Vial, For IM & Regional Injection, Rx only, Compounded by US Compounding Pharmacy, Conway, Arkansas, 72032, NDC 62295-3122-07", "product_quantity": "11,363 vials", "reason_for_recall": "Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.", "recall_initiation_date": "20150912", "center_classification_date": "20151117", "termination_date": "20170330", "report_date": "20151125", "code_info": "Lot Numbers: 20150707@31 BUD: 1/3/2016, 20150707@36 BUD: 1/3/2016, 20151106@19 BUD: 12/8/2015, 20151604@24 BUD: 10/13/2015, 20151606@20 BUD: 12/13/2015, 20151805@60 BUD: 11/14/2015, 20152105@35 BUD: 11/17/2015, 20153103@13 BUD: 9/27/2015"}, {"country": "United States", "city": "Harriman", "address_1": "144 Route 17m Ste 4", "reason_for_recall": "Penicillin Cross Contamination: potentially contaminated with penicillin", "address_2": "", "product_quantity": "", "code_info": "All lots", "center_classification_date": "20151202", "distribution_pattern": "Nationwide", "state": "NY", "product_description": "TRI-EST Liquids, Rx, compounded by Life Science Pharmacy Inc., Harriman, NY", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Life Science Pharmacy Inc", "recall_number": "D-0503-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71494", "termination_date": "20180611", "more_code_info": "", "recall_initiation_date": "20150608", "postal_code": "10926-3321", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lawrence", "state": "KS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90398", "recalling_firm": "Plastikon Healthcare LLC", "address_1": "3780 Greenway Cir", "address_2": "N/A", "postal_code": "66046-5440", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-1491-2022", "product_description": "GUAIFENESIN AND DEXTROMETHORPHAN 200-20 mg/10 mL, 10 mL cup, packaged in 10 cups per tray, 10 trays per carton, For Institutional Use Only, Major Pharmaceuticals, 17177 N Laurel Park Dr. Suite 233, Livonia, MI 48152, NDC 0904-6980-72", "product_quantity": "246,200 cups", "reason_for_recall": "CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.", "recall_initiation_date": "20220607", "center_classification_date": "20220906", "termination_date": "20250625", "report_date": "20220914", "code_info": "Lot # 20091A, EXP Sep. 2022; 20104A, EXP Nov. 2022; 21017A, EXP Feb. 2023; 21034A, 21036A EXP Mar. 2023; 21092A, EXP Aug. 2023; 21105A, 21106A, EXP Oct. 2023; 21134A, EXP Dec. 2023; 22007B, EXP Jan. 2024; 22012A, EXP Feb. 2024; 22016B, EXP Mar. 2024"}, {"status": "Terminated", "city": "Las Vegas", "state": "NV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74187", "recalling_firm": "Well Care Compounding Pharmacy", "address_1": "3430 E Tropicana Ave Ste 9", "address_2": "N/A", "postal_code": "89121-7345", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "NV", "recall_number": "D-0983-2016", "product_description": "ESTRADIOL VALERATE 20MG/ML, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121", "product_quantity": "869 Units (Total All Products)", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.", "recall_initiation_date": "20160517", "center_classification_date": "20160609", "termination_date": "20170113", "report_date": "20160615", "code_info": "Lot #: 04112016:76@67, Exp.07/12/2016"}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0281-2018", "product_description": "Medline GHS Suture Removal Tray, Sterile, Single Use Only. Packaged in USA for Medline Industries, Inc., Mundelein, IL 60060", "product_quantity": "1100 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Pack Number: DYNDR1056; Lots: 17RB9450", "more_code_info": ""}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83789", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0068-2020", "product_description": "LIDOcaine HCl 1% (PF) 50 mg/5 mL (10 mg/mL), 5 mL Fill in a 6 mL Single Dose Syringe, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321678424", "product_quantity": "2565 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190912", "center_classification_date": "20191001", "termination_date": "20210819", "report_date": "20191009", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-167-2014", "product_description": "Lincomycin 300mg, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "33 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74057", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1400-2016", "product_description": "2 mcg/mL Fentanyl Citrate and 0.167% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 200 mL in 250 mL Baxter Intravia Bag, Service Code 2K9276, Rx Only,  Compounded by PharMEDium Services, LLC, Memphis, TN 36141, NDC 61553-276-98", "product_quantity": "480 bags", "reason_for_recall": "Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.", "recall_initiation_date": "20160505", "center_classification_date": "20160716", "termination_date": "20180306", "report_date": "20160727", "code_info": "Lot Number 160480033C , Exp. Date 5/12/2016 ;  Lot Number 160520027C , Exp. Date 5/16/2016 ;  Lot Number 160610040C , Exp. Date 5/25/2016 ;  Lot Number 160750051C , Exp. Date 6/8/2016 ;  Lot Number 160800038C , Exp. Date 6/13/2016 ;  Lot Number 160880045C , Exp. Date 6/21/2016 ;  Lot Number 160940037C , Exp. Date 6/27/2016 ;  Lot Number 160960035C , Exp. Date 6/29/2016 ;", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0204-2021", "product_description": "PHENYLephrine HCl 1000 mcg/10 mL in 0.9% Sodium Chloride, (100 mcg/mL) Rx Only, 10 mL Single Dose Syringe, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT,  06095, barcode 70004081012", "product_quantity": "23,029 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "Lot # 1220022957, BUD 1/20/2021; 1220022993, BUD 1/21/2021;  1220023020, BUD 1/14/2021;  1220023037, BUD 1/19/2021; 1220023038, BUD 1/20/2021; 1220023074, 1/24/2021; 1220023103, BUD 1/24/2021; 1220023160, BUD 1/26/2021;  1220023180, BUD 1/27/2021; 1220023183, BUD 1/27/2021; 1220023216, BUD 1/28/2021;  1220023267, BUD 2/1/2021; 1220023272, BUD 1/3/2021; 1220023344, BUD 2/10/2021;  1220023387, BUD 2/9/2021; 1220023475,BUD 2/4/2021; 1220023479, BUD 2/4/2021; 1220023564, BUD 2/9/2021;  1220023565, BUD 2/9/2021; 1220023587, BUD 2/10/2021 &  1220023624, BUD 2/11/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Pomona", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "55714", "recalling_firm": "K C Pharmaceuticals Inc", "address_1": "3201 Producer Way", "address_2": "N/A", "postal_code": "91768-3916", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-192-2013", "product_description": "Eye Drops advanced relief (Dextran 70 0.1%, Polyethylene glycol 400 1%, Povidone 1%, Tetrahydrozoline HCl 0.05%) ophthalmic solution, 1/2 fl oz (15 mL) bottle, Distributed By Dolgencorp, LLC, 100 Mission Ridge, Goodlettsville, TN  37072.", "product_quantity": "31,704 bottles", "reason_for_recall": "Labeling: Label Mix-Up: Incorrect back labeling of the immediate container of eye drops (unit carton and front label are correct) which do not list three active ingredients: Dextran 70, PEG 400, and povidone.", "recall_initiation_date": "20100301", "center_classification_date": "20130308", "termination_date": "20130402", "report_date": "20130320", "code_info": "Lot #: 9P367, Exp 12/12", "more_code_info": ""}, {"status": "Terminated", "city": "Littleton", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83397", "recalling_firm": "Wise Pharmacy", "address_1": "6179 S Balsam Way Ste 150", "address_2": "N/A", "postal_code": "80123-3095", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CO, TX, WY", "recall_number": "D-1568-2019", "product_description": "Alprostadil 100 mcg/mL Injectable, 2.5 mL vial, Rx only, Compounded by Wise Pharmacy, Littleton, CO 80123.", "product_quantity": "4 vials", "reason_for_recall": "Lack of Processing Controls", "recall_initiation_date": "20190722", "center_classification_date": "20190731", "termination_date": "20200203", "report_date": "20190807", "code_info": "Lot #: 6981N, Exp 10/17/2019"}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0255-2017", "product_description": "Calm Me (Aminobutyric Acid (GABA) 50 mg/Magnesium Chloride 50 mg/Taurine 50 mg/Theanine (L) 50 mg/Tryptophan (L) 10 mg/Lidocaine HCL 10 mg/ml), (30 ML).  Compounded by Tri-Coast Pharmacy.", "product_quantity": "10 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.     Known lot codes (Exp Date): 09212016A (01/31/2017), 08032016C (01/31/2017)."}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA208368"], "brand_name": ["CINACALCET"], "generic_name": ["CINACALCET"], "manufacturer_name": ["Dr. Reddys Laboratories Inc"], "product_ndc": ["43598-367", "43598-368", "43598-369"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CINACALCET HYDROCHLORIDE"], "rxcui": ["432400", "432401", "432402"], "spl_id": ["b6dbd55a-a71d-0cf8-2c73-7ebbfc032906"], "spl_set_id": ["0837aabc-e796-0e07-8958-71f1ff6e89bf"], "package_ndc": ["43598-367-30", "43598-367-05", "43598-368-30", "43598-368-05", "43598-369-30", "43598-369-05"], "is_original_packager": [true], "upc": ["0343598369303"], "unii": ["1K860WSG25"]}, "product_type": "Drugs", "event_id": "95500", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide.", "recall_number": "D-0026-2025", "product_description": "Cinacalcet Tablets, 30 mg, 30-count bottle, Rx Only, Dr. Reddy's Laboratories Inc, Princeton, NJ 08540, Made in India, NDC 43598-367-30.", "product_quantity": "285126 bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit", "recall_initiation_date": "20241009", "center_classification_date": "20241028", "report_date": "20241106", "code_info": "Lot# T2200120, T2200121, T2200119, T2200116, T2200118, T2200117, Exp 11/2024; T2200695, T2200694, T2200696, T2200697, Exp 01/2025; T2201426, T2201428, T2201432, T2201427, T2201430, T2201429, T2201431, Exp 03/2025; T2202743, T2202742, T2202741, & T2202740, Exp 06/2025; T2203081, T2203079, T2203080, T2203082, T2203083 & T2203084, Exp 07/2025; T2300770, T2300771, T2300769, T2300766, T2300767 & T2300768, Exp 12/2025  Lots T2301663, T2301665, T2301662, T2301664, T2301667, T2301661, T2301666, T2301660, T2301658 & T2301659, Exp Date 02/2026  Lots T2304704, T2304703, T2304705, T2304706, Exp Date 08/2026  Lots T2400468, T2400469, T2400473 & T2400474 Exp Date 11/2026", "more_code_info": ""}, {"country": "United States", "city": "East Windsor", "address_1": "279 Princeton Hightstown Rd", "reason_for_recall": "CGMP DEVIATIONS: One lot of Ranitidine Tablets USP, 150 mg is being recalled because some bottles were empty.", "address_2": "", "product_quantity": "69696 bottles", "code_info": "Lot #: NBSB19001DA3, Exp. date 02/2021", "center_classification_date": "20191029", "distribution_pattern": "Nationwide within the United States", "state": "NJ", "product_description": "Ranitidine Tablets USP,150 mg,  8-count bottles,  Distributed by: Dolgencorp, LLC, 100 Mission Ridge, Goodlettsville, TN 37073 Made in India NDC 55910-092-79", "report_date": "20191106", "classification": "Class III", "openfda": {}, "recalling_firm": "AuroMedics Pharma LLC", "recall_number": "D-0166-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "83868", "more_code_info": "", "recall_initiation_date": "20190923", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"country": "United States", "city": "Easton", "address_1": "8050 Industrial Park Rd", "reason_for_recall": "Labeling: Label Error on Declared Strength; Listed active ingredient strength is inaccurate.", "address_2": "", "product_quantity": "6286 Bottles", "code_info": "Lot #: A44701 (expiry:  07/16) , A44701C (expiry: 07/16), J34701C-1 (expiry: 07/16)", "center_classification_date": "20140513", "distribution_pattern": "USA including FL, MN,  NY, OH, OR, PA, TX, SC and Puerto Rico; Dominican Republic.", "state": "MD", "product_description": "PSYLLIUM FIBER, Laxative/Supplement, 100 Capsules, OTC.  Manufactured By: Konsyl Pharmaceuticals, Inc., Easton, MD 21601. NDC: 0224-1847-10.", "report_date": "20140521", "classification": "Class III", "openfda": {}, "recalling_firm": "Konsyl Pharmaceuticals Inc", "recall_number": "D-1315-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "68052", "termination_date": "20160526", "more_code_info": "", "recall_initiation_date": "20140401", "postal_code": "21601-8602", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65019", "recalling_firm": "Nora Apothecary and Alternative Therapies, Inc.", "address_1": "1101 E 86th St", "address_2": "N/A", "postal_code": "46240-3729", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-474-2013", "product_description": "PHMB Opth Soln 0.02%, 10 ml  Opthalmic Soln, 30 day expiration,", "product_quantity": "2", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.", "recall_initiation_date": "20130422", "center_classification_date": "20130529", "termination_date": "20140801", "report_date": "20130605", "code_info": "All products within their expiration date including those dated 90 days prior to April 19, 2013 (Jan. 2013 to April 19, 2013)."}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "65383", "recalling_firm": "Dolphin Intertrade Corporation", "address_1": "11314 Sw 135th Ct", "address_2": "N/A", "postal_code": "33186-4425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1250-2014", "product_description": "XIYOUJI QINGZHI CAPSULE, 300mg, 20 count box", "product_quantity": "8 bottles", "reason_for_recall": "Marketed without an Approved NDA/ANDA: Products found to contain undeclared sibutramine. Sibutramine was removed from the U.S. market for safety reasons, making these products unapproved new drugs.", "recall_initiation_date": "20130520", "center_classification_date": "20140418", "termination_date": "20160629", "report_date": "20140430", "code_info": "All Lots", "more_code_info": ""}, {"status": "Ongoing", "city": "Rafelbunol", "state": "N/A", "country": "Spain", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73574", "recalling_firm": "Sesderma, SL", "address_1": "Calle Massamagrell 3-5", "address_2": "Poligono Industrial Rafelbunol", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Distributed to following states: FL, PR, CO, GA.", "recall_number": "D-0849-2016", "product_description": "Repaskin 30 (octacrylene 4%, oxybenzone 3%, octisalate 3%, octinoxate 3% Avobenzone 3%) Facial Sunscreen gel cream, Broad Spectrum SPF 30, 1.7 fl oz (50 mL) bottle, over the counter, Manufactured by Sesderma S.L., Valencia, Spain, NDC 63181-0010-1", "product_quantity": "27 bottles", "reason_for_recall": "cGMP Deviations; product does not comply with cGMP requirements", "recall_initiation_date": "20151015", "center_classification_date": "20160510", "report_date": "20160518", "code_info": "Lot code 51064901, exp 07/17; Lot code 51064902, exp 04/18"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209239"], "brand_name": ["SOLIFENACIN SUCCINATE"], "generic_name": ["SOLIFENACIN SUCCINATE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-386", "68462-387"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SOLIFENACIN SUCCINATE"], "rxcui": ["477367", "477372"], "spl_id": ["9cfcab1d-64ac-457b-979f-41cf6547a63a"], "spl_set_id": ["010c0657-c907-477f-8bd7-5d455a5f50eb"], "package_ndc": ["68462-386-30", "68462-386-90", "68462-386-14", "68462-387-30", "68462-387-90", "68462-387-14"], "is_original_packager": [true], "upc": ["0368462386309", "0368462387306"], "unii": ["KKA5DLD701"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0317-2025", "product_description": "Solifenacin Succinate Tablets 10MG, a. 30-count bottle (NDC# 68462-387-30),  b. 90-Count Bottle (NDC 68462-387-90),Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot # 17230762, exp. date Mar-25"}, {"country": "United States", "city": "Oklahoma City", "address_1": "755 Research Pkwy Ste 150", "reason_for_recall": "Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.", "address_2": "", "product_quantity": "", "code_info": "all lot codes", "center_classification_date": "20140729", "distribution_pattern": "Nationwide", "state": "OK", "product_description": "Dermamedics Calm and Correct Serum, 2 oz. containers with a SKU number of BB10062 and 4 oz. containers with a SKU number of BB10068.", "report_date": "20140806", "classification": "Class II", "openfda": {}, "recalling_firm": "Dermamedics, L.L.C.", "recall_number": "D-1491-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "67247", "termination_date": "20170314", "more_code_info": "", "recall_initiation_date": "20140110", "postal_code": "73104-3621", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA204022"], "brand_name": ["ROPINIROLE"], "generic_name": ["ROPINIROLE"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-232", "16729-233", "16729-234", "16729-235", "16729-236", "16729-237", "16729-238"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ROPINIROLE HYDROCHLORIDE"], "rxcui": ["283858", "312845", "312846", "312847", "312849", "314208", "562704"], "spl_id": ["23980eef-2eb5-2b74-e063-6394a90a68ac"], "spl_set_id": ["4a2a5b63-5b14-6975-e054-00144ff8d46c"], "package_ndc": ["16729-232-01", "16729-233-01", "16729-234-01", "16729-235-01", "16729-236-01", "16729-237-01", "16729-238-01"], "is_original_packager": [true], "unii": ["D7ZD41RZI9"], "upc": ["316729233019"]}, "product_type": "Drugs", "event_id": "91657", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and Canada", "recall_number": "D-0426-2023", "product_description": "rOPINIRole Tablets USP 0.5 mg*, 100-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213 INDIA. NDC 16729-233-01, UPC 3 16729 23301 9", "product_quantity": "181,848 bottles", "reason_for_recall": "CGMP Deviations: recalling drug products following an FDA inspection.", "recall_initiation_date": "20230207", "center_classification_date": "20230302", "termination_date": "20240422", "report_date": "20230308", "code_info": "Batches: P2102133, P2102135, P2102136, Exp. Date 3/31/2023, P2104998, P2104997, P2104991, P2104992, P2104990, P2104993, P2105000, P2104999, P2105002, P2105001, Exp. Date 7/31/2023, P2106812, Exp. Date, 9/30/2023, P2200433, P2200434, P2200435, Exp. Date, 12/31/2023, P2202730, P2202729, Exp. Date 4/30/2024, P2203517, Exp. Date 5/31/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Moses Lake", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71806", "recalling_firm": "JD & SN Inc., dba Moses Lake Professional Pharmacy", "address_1": "1555 Pilgrim St", "address_2": "N/A", "postal_code": "98837-4623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0109-2016", "product_description": "METHYLCOBALAMIN PRESERVATIVE FREE PREFILLED, Injectable Solution,1 mg/mL, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA  98837, (509)764-2314", "product_quantity": "36 syringes", "reason_for_recall": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry", "recall_initiation_date": "20150724", "center_classification_date": "20151027", "termination_date": "20160413", "report_date": "20151104", "code_info": "t07142015@46"}, {"status": "Terminated", "city": "Bristol", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021301"], "brand_name": ["LEVOXYL"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "product_ndc": ["60793-850", "60793-851", "60793-852", "60793-853", "60793-854", "60793-855", "60793-856", "60793-857", "60793-858", "60793-859", "60793-860"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "966157", "966164", "966170", "966175", "966184", "966190", "966194", "966200", "966204", "966211", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270", "966283"], "spl_id": ["e230c170-2a16-47d0-bce7-ac0414c192f7"], "spl_set_id": ["758588c3-c63e-491b-0aa2-4f50d80cb174"], "package_ndc": ["60793-850-10", "60793-850-01", "60793-851-10", "60793-851-01", "60793-852-10", "60793-852-01", "60793-853-10", "60793-853-01", "60793-854-10", "60793-854-01", "60793-855-10", "60793-855-01", "60793-856-10", "60793-856-01", "60793-857-10", "60793-857-01", "60793-858-10", "60793-858-01", "60793-859-10", "60793-859-01", "60793-860-10", "60793-860-01"], "is_original_packager": [true], "upc": ["0360793856018", "0360793850016", "0360793852010", "0360793851013", "0360793857015", "0360793853017", "0360793854014", "0360793858012", "0360793855011", "0360793859019", "0360793860015"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "65172", "recalling_firm": "King Legacy, a wholly owned subsidiary of Pfizer", "address_1": "501 5th Street", "address_2": "N/A", "postal_code": "37620-2304", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-427-2013", "product_description": "Levoxyl (levothyroxine sodium) tablets, USP, 125 mcg, packaged in a) 100-count bottles (NDC 60793-856-01) and b) 1000-count bottles (NDC 60793-856-10), Rx only, Manufactured and Distributed by:  King Pharmaceuticals, Inc., Bristol, TN  37620", "product_quantity": "103,796 bottles", "reason_for_recall": "Subpotent Drug: The products were below specification for potency at the expiry stability point.", "recall_initiation_date": "20130430", "center_classification_date": "20130520", "termination_date": "20160630", "report_date": "20130529", "code_info": "Lot # a) 64333, Exp. 5/13; 64937, Exp. 6/13; 65629, Exp. 7/13; and 66296, Exp. 9/13; b) 64931, Exp. 5/13 and 65766, Exp. 7/13"}, {"status": "Terminated", "city": "Abbott Park", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021402"], "brand_name": ["SYNTHROID"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["AbbVie Inc."], "product_ndc": ["0074-3727", "0074-4341", "0074-4552", "0074-5182", "0074-6594", "0074-6624", "0074-9296", "0074-7068", "0074-7069", "0074-7070", "0074-7148", "0074-7149"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966158", "966171", "966185", "966191", "966201", "966205", "966218", "966220", "966221", "966222", "966224", "966225", "966247", "966248", "966249", "966250", "966251", "966253", "966270", "966271", "966282"], "spl_id": ["b85ab7fa-ba96-43cd-b736-44b3924e644c"], "spl_set_id": ["1e11ad30-1041-4520-10b0-8f9d30d30fcc"], "package_ndc": ["0074-4341-13", "0074-4341-90", "0074-4341-19", "0074-4341-72", "0074-4552-13", "0074-4552-90", "0074-4552-19", "0074-4552-11", "0074-4552-71", "0074-4552-72", "0074-5182-13", "0074-5182-90", "0074-5182-71", "0074-5182-19", "0074-5182-11", "0074-5182-72", "0074-6594-13", "0074-6594-90", "0074-6594-71", "0074-6594-19", "0074-6594-72", "0074-6624-13", "0074-6624-90", "0074-6624-19", "0074-6624-11", "0074-6624-71", "0074-6624-72", "0074-9296-13", "0074-9296-90", "0074-9296-19", "0074-9296-71", "0074-9296-72", "0074-7068-13", "0074-7068-90", "0074-7068-71", "0074-7068-19", "0074-7068-11", "0074-7068-72", "0074-3727-13", "0074-3727-90", "0074-3727-71", "0074-3727-19", "0074-3727-72", "0074-7069-90", "0074-7069-71", "0074-7069-19", "0074-7069-11", "0074-7069-72", "0074-7070-13", "0074-7070-90", "0074-7070-71", "0074-7070-19", "0074-7070-72", "0074-7148-90", "0074-7148-19", "0074-7148-71", "0074-7148-11", "0074-7148-72", "0074-7149-90", "0074-7149-19"], "is_original_packager": [true], "upc": ["0300747070190", "0300747069903", "0300749296192", "0300743727906", "0300747148905", "0300746624905", "0300747149902", "0300747068197", "0300744341194", "0300745182192"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "63791", "recalling_firm": "Abbott Laboratories", "address_1": "100 Abbott Park Rd", "address_2": "N/A", "postal_code": "60064-3502", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide and Puerto Rico", "recall_number": "D-107-2013", "product_description": "Synthroid (Levothyroxine Sodium) tablets, 150 mcg (0.15 mg), 90 tablets per bottle, Rx Only, NDC 0074-7069-90; ABBOTT LABORATORIES NORTH CHICAGO, IL 60064 U.S.A.", "product_quantity": "28, 524 bottles", "reason_for_recall": "Labeling: Error on Declared Strength. Product labeled to contain 150 mcg tablets actually contained 75 mcg tablets.", "recall_initiation_date": "20121204", "center_classification_date": "20121228", "termination_date": "20150710", "report_date": "20130109", "code_info": "LOT # 18262A8  Exp. 09/13"}, {"status": "Terminated", "city": "Pointe-Claire", "state": "N/A", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78887", "recalling_firm": "Odan Laboratories Ltd", "address_1": "325 Stillview Ave", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "distributed nationwide in the USA", "recall_number": "D-0232-2018", "product_description": "Dry to Normal Skin Starter Kit, Trousse debutante pour peau seche a normale. Kit includes:  (Vegetable Cleanser (60 ml / 2 oz), Night Cream (15 g / 0.5 oz), Day Cream SPF15 {Octinoxate 7%, Avobenzone 2% and Oxybenzone 5%} (15 g / 0.5 oz), Eye Cream (6 g / 0.21 oz).Made in Canada, Kamins Dermatologics Inc. Montreal, Quebec H9R 2Y6. Distributed by Kamins Dermatologics (USA) Inc. 99 Hudson, New York, NY, USA. UPC code 6 06354 61322 4", "product_quantity": "179 kits", "reason_for_recall": "Failed Stability Specifications:stability failure at 12 months, long term RT conditions.", "recall_initiation_date": "20171220", "center_classification_date": "20180124", "termination_date": "20180618", "report_date": "20180131", "code_info": "Lots # J203, J204, EXP 02-2018; J228, J274, EXP 09-2018"}, {"status": "Terminated", "city": "Salisbury", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203534"], "brand_name": ["IRBESARTAN"], "generic_name": ["IRBESARTAN"], "manufacturer_name": ["Jubilant Cadista Pharmacuticals Inc."], "product_ndc": ["59746-447", "59746-448", "59746-449"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["IRBESARTAN"], "rxcui": ["200094", "200095", "200096"], "spl_id": ["fe513bc0-f78d-4c5c-a54e-279b268fe5e3"], "spl_set_id": ["068224c4-a34d-32d7-bb2a-7eed44ccf7d3"], "package_ndc": ["59746-447-30", "59746-447-90", "59746-447-05", "59746-448-30", "59746-448-90", "59746-448-05", "59746-449-30", "59746-449-90", "59746-449-05"], "is_original_packager": [true], "upc": ["0359746449308", "0359746448301", "0359746447304"], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["J0E2756Z7N"]}, "product_type": "Drugs", "event_id": "90610", "recalling_firm": "Jubilant Cadista Pharmaceuticals, Inc.", "address_1": "207 Kiley Dr", "address_2": "", "postal_code": "21801-2249", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1293-2022", "product_description": "Irbesartan Tablets, USP, 150mg, 90- count bottles, Rx only, Manufactured by: Jubilant Generics Ltd. Roorkee- 247661, India, Marketed by: Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-448-90", "product_quantity": "9,600 bottles", "reason_for_recall": "Failed dissolution specifications.", "recall_initiation_date": "20220718", "center_classification_date": "20220726", "termination_date": "20221122", "report_date": "20220803", "code_info": "Lot #: IB220023A, exp. date 08/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65019", "recalling_firm": "Nora Apothecary and Alternative Therapies, Inc.", "address_1": "1101 E 86th St", "address_2": "N/A", "postal_code": "46240-3729", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-482-2013", "product_description": "Hydroxycobalamin Inj 2500 mcg/ml MDV, 2x30ml  Subcutaneous, 90 day expiration,", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.", "recall_initiation_date": "20130422", "center_classification_date": "20130529", "termination_date": "20140801", "report_date": "20130605", "code_info": "All products within their expiration date including those dated 90 days prior to April 19, 2013 (Jan. 2013 to April 19, 2013)."}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "86193", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "N/A", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S.", "recall_number": "D-1551-2020", "product_description": "Heparin Sodium 5,000 units in 0.9% Sodium Chloride 500 mL, Single Dose Container, Rx Only Injection for Intravenous Use (10 units/mL), SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC#: 70004-0650-44, Bar Code 70004065044.", "product_quantity": "366 Containers", "reason_for_recall": "Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylparaben as preservatives, actually contained undeclared benzyl alcohol and did not contain any parabens.", "recall_initiation_date": "20200729", "center_classification_date": "20200827", "termination_date": "20210521", "report_date": "20200902", "code_info": "Lot #: 1220019289, Exp 08/21/2020."}, {"status": "Terminated", "city": "Brooklyn", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83136", "recalling_firm": "Infusion Options, Inc.", "address_1": "5924 13th Ave", "address_2": "N/A", "postal_code": "11219-4934", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY only", "recall_number": "D-1755-2019", "product_description": "CALCIUM GLUCONATE 1 GM /100 ML NACL 0.9% IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190612", "center_classification_date": "20190815", "termination_date": "20250321", "report_date": "20190821", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Grand Island", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA076972"], "brand_name": ["ONDANSETRON"], "generic_name": ["ONDANSETRON HYDROCHLORIDE"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "product_ndc": ["63323-373", "63323-374"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["ONDANSETRON HYDROCHLORIDE"], "rxcui": ["283504", "1740467"], "spl_id": ["83824969-e116-40d6-8940-ff134a4f16c0"], "spl_set_id": ["e0050959-c14c-41b6-9a92-fadc5f6feff3"], "package_ndc": ["63323-373-00", "63323-373-02", "63323-374-20"], "is_original_packager": [true], "upc": ["0363323374204", "0363323373009"], "unii": ["NMH84OZK2B"]}, "product_type": "Drugs", "event_id": "82915", "recalling_firm": "Fresenius Kabi USA, LLC", "address_1": "3159 Staley Rd", "address_2": "N/A", "postal_code": "14072-2028", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1386-2019", "product_description": "Ondansetron Injection, USP, 40 mg / 20 mL, 20 mL vial, Rx Only, Fresenius Kabi USA, LLC, Lake Zurich, IL 60047, NDC 63323-374-20", "product_quantity": "11,981 units", "reason_for_recall": "Failed Impurities/Degradation Specifications.", "recall_initiation_date": "20190522", "center_classification_date": "20190614", "termination_date": "20210128", "report_date": "20190619", "code_info": "Lot #: 6018699, Exp. 12/2021"}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90566", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1447-2022", "product_description": "JOHNSONS BABY FIRST TOUCH GIFT SET 4PC distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: product held outside appropriate storage temperature conditions.", "recall_initiation_date": "20220623", "center_classification_date": "20220822", "report_date": "20220831", "code_info": "SKU: 999553", "more_code_info": ""}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "1 vial", "code_info": "Lot # t02-01-2017@119, Exp 5/3/2017.", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "CO-Q-10 OIL 20ML MDV (CALIF) 25MG/ML INJ,  Injection,  25mg/mL, Rx only, 20mL Glass /Multiple Dose vial, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0713-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Latham", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70807", "recalling_firm": "Fallon Wellness Pharmacy, L.L.C.", "address_1": "1057 Troy Schenectady Rd", "address_2": "N/A", "postal_code": "12110-1002", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "New York", "recall_number": "D-1066-2015", "product_description": "Methylcobalamin/Hydroxocobalamin Rx 3.125/3.125 mg/0.5 mL Injection, Fallon Wellness Pharmacy, L.L.C., Latham, NY 12110", "product_quantity": "30 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20150317", "center_classification_date": "20150512", "termination_date": "20180605", "report_date": "20150520", "code_info": "Lot#: 01272015@38, Exp 3/28/15", "more_code_info": ""}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0187-2022", "product_description": "TRI-MIX PAPAVERINE 15/PHENTOLAMINE 0.5/PGE-1 5 INJ   INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "2 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 07292021:21 BUD: 11/30/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077584"], "brand_name": ["PAROXETINE"], "generic_name": ["PAROXETINE"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["68382-001", "68382-097", "68382-098", "68382-099"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PAROXETINE HYDROCHLORIDE HEMIHYDRATE"], "rxcui": ["1738483", "1738495", "1738503", "1738511"], "spl_id": ["c88d98d1-e370-4ad8-869a-603875f276cc"], "spl_set_id": ["a6bb4f0a-1555-4550-a7a4-99609674b1e7"], "package_ndc": ["68382-097-16", "68382-097-01", "68382-097-05", "68382-097-10", "68382-097-06", "68382-098-06", "68382-098-16", "68382-098-01", "68382-098-05", "68382-098-10", "68382-099-06", "68382-099-16", "68382-099-01", "68382-099-05", "68382-099-10", "68382-001-06", "68382-001-16", "68382-001-01", "68382-001-05", "68382-001-10", "6838209906"], "is_original_packager": [true], "upc": ["0368382098108", "0368382099105", "368382099068"], "unii": ["X2ELS050D8"]}, "product_type": "Drugs", "event_id": "77963", "recalling_firm": "Zydus Pharmaceuticals USA Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within United States", "recall_number": "D-1137-2017", "product_description": "Paroxetine tablets USP, 30mg, 30-count bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA, Inc., Pennington, NJ 08534, NDC 68382-099-06, UPC 3 6838209906 8", "product_quantity": "44800 bottles", "reason_for_recall": "Presence of Foreign tablets/capsules: risperidone Tablets were found in bottle of paroxetine Tablets", "recall_initiation_date": "20170818", "center_classification_date": "20170911", "termination_date": "20200106", "report_date": "20170920", "code_info": "Lot #: Z701133, Exp 03/19"}, {"status": "Terminated", "city": "Dawsonville", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090295"], "brand_name": ["METFORMIN HYDROCHLORIDE EXTENDED RELEASE"], "generic_name": ["METFORMIN HYDROCHLORIDE"], "manufacturer_name": ["direct rx"], "product_ndc": ["72189-064", "72189-150"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METFORMIN HYDROCHLORIDE"], "rxcui": ["860975"], "spl_id": ["2c4ea7fa-b789-8bdf-e063-6394a90a3e5a"], "spl_set_id": ["a84cf1a3-3820-cd1b-e053-2995a90acf45"], "package_ndc": ["72189-150-90", "72189-150-30", "72189-064-90", "72189-064-30"], "original_packager_product_ndc": ["51224-007", "49483-623"], "unii": ["786Z46389E"]}, "product_type": "Drugs", "event_id": "86601", "recalling_firm": "Direct Rx", "address_1": "94 Worldwide Dr", "address_2": "N/A", "postal_code": "30534-6828", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL", "recall_number": "D-0058-2021", "product_description": "Metformin HCL E/R 500 mg, 90 Tabs, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534  NDC 72189-064-90", "product_quantity": "88 bottles", "reason_for_recall": "CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)", "recall_initiation_date": "20201012", "center_classification_date": "20201102", "termination_date": "20210922", "report_date": "20201111", "code_info": "Lot: 04DE1902, 11DE1908 Exp. 06/30/2021"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA090383"], "brand_name": ["SIMVASTATIN"], "generic_name": ["SIMVASTATIN"], "manufacturer_name": ["Micro Labs Limited"], "product_ndc": ["42571-005", "42571-010", "42571-020", "42571-040", "42571-080"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SIMVASTATIN"], "rxcui": ["198211", "200345", "312961", "312962", "314231"], "spl_id": ["0369d423-9ef2-0191-e063-6294a90a55e7"], "spl_set_id": ["5c1c694c-4b08-469e-b538-08e69df06146"], "package_ndc": ["42571-010-30", "42571-010-60", "42571-010-90", "42571-010-05", "42571-010-10", "42571-005-30", "42571-005-60", "42571-005-90", "42571-005-05", "42571-005-10", "42571-020-30", "42571-020-60", "42571-020-90", "42571-020-05", "42571-020-10", "42571-040-30", "42571-040-60", "42571-040-90", "42571-040-05", "42571-040-10", "42571-080-30", "42571-080-60", "42571-080-90", "42571-080-05", "42571-080-10"], "is_original_packager": [true], "upc": ["0342571010300", "0342571040307", "0342571020309", "0342571005306", "0342571080303"], "nui": ["N0000175589", "N0000000121"], "pharm_class_epc": ["HMG-CoA Reductase Inhibitor [EPC]"], "pharm_class_moa": ["Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]"], "unii": ["AGG2FN16EV"]}, "product_type": "Drugs", "event_id": "69928", "recalling_firm": "Micro Labs Usa, Inc                                    S", "address_1": "104 Carnegie Ctr", "address_2": "Te 216", "postal_code": "08540-6232", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide.", "recall_number": "D-0409-2015", "product_description": "Simvastatin Tablets, USP, 80mg, Rx Only, 90 count bottles, Manufactured by: Micro Labs Limited Goa-403 722, India, Manufactured for: Micro Labs USA Inc.,   Princeton, NJ 08540 NDC 42571-080-90.", "product_quantity": "13464 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Product failed a known impurity specification.", "recall_initiation_date": "20141204", "center_classification_date": "20150311", "termination_date": "20180425", "report_date": "20150318", "code_info": "Lot #: STEG004, Exp 2/2015; Lot #: STEG006 Exp 3/2015"}]